Use of hydroxyethyl starch in sepsis research: A systematic review with meta-analysis

被引:3
|
作者
Johansen, Jes R. [1 ]
Perner, Anders [1 ]
Brodtkorb, Julie H. [1 ]
Moller, Morten H. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Intens Care, Copenhagen, Denmark
关键词
adverse effects; hydroxyethyl starch (HES) 130/0.38-0.45; sepsis; RESUSCITATION; 6-PERCENT; MANAGEMENT; OUTCOMES; SALINE;
D O I
10.1111/aas.13954
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: After being used for more than a decade the use of hydroxyethyl starch (HES) 130/0.38-0.45 in clinical practice was discouraged because of serious adverse events including bleeding, acute kidney injury and death. But could these adverse effects have been discovered sooner? By comparing the summary effect estimates of the adverse effects of HES 130/0.38-0.45 in different study designs we aimed to disclose any signal of this. Methods: We systematically searched MEDLINE, EMBASE and Cochrane Library and hand-searched the reference lists of relevant studies to identify studies for inclusion. Eligible trials were randomised clinical trials (RCTs) and observational studies in patients with sepsis and randomised trials in animals with induced sepsis comparing HES 130/0.38-0.45 to any type of crystalloid. Relevant outcomes were all-cause mortality at longest follow-up, renal replacement therapy (RRT), acute kidney injury (AKI) and bleeding. We extracted data, conducted conventional meta-analyses and assessed the risk of bias and the quality of evidence. Results: We included 8 RCTs including 3,273 patients, 1 observational study including 379 patients and 5 randomised animal trials including 94 test animals. There was no suggestion of interaction in subgroup analyses comparing the different study designs for any outcomes (all-cause mortality at longest follow-up p = .33; RRT p = .70; AKI p = .63; bleeding p = .20). Conclusions: We observed no interaction between the summary effect estimates of RCTs, observational studies in patients and randomised animal trials for any of the outcomes. Accordingly, we found no evidence indicating that the adverse effects of HES 130/0.38-0.45 could have been discovered sooner. Systematic review registration: PROSPERO ID: CRD42018103422. Protocol Johansen JR, Perner A, Brodtkorb JH, Moller MH. Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review. Acta Anaesthesiol Scand. 2019;63:814-818.
引用
收藏
页码:1355 / 1364
页数:10
相关论文
共 50 条
  • [41] Safety and efficacy of peri-operative administration of hydroxyethyl starch in children undergoing surgery A systematic review and meta-analysis
    Thy, Michael
    Montmayeur, Juliette
    Julien-Marsollier, Florence
    Michelet, Daphne
    Brasher, Christopher
    Dahmani, Souhayl
    Orliaguet, Gilles
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2018, 35 (07) : 484 - 495
  • [42] Examining the use of network meta-analysis in pharmacy services research: A systematic review
    Teoh, Kah Woon
    Khan, Tahir Mehmood
    Chaiyakunapruk, Nathorn
    Lee, Shaun Wen Huey
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (06) : 787 - +
  • [43] Use of dexmedetomidine in patients with sepsis: a systematic review and meta-analysis of randomized-controlled trials
    Zhang, Ting
    Mei, Qimin
    Dai, Shabai
    Liu, Yecheng
    Zhu, Huadong
    ANNALS OF INTENSIVE CARE, 2022, 12 (01)
  • [44] Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis
    Rochwerg, B.
    Alhazzani, W.
    Gibson, A.
    Ribic, C. M.
    Sindi, A.
    Heels-Ansdell, D.
    Thabane, L.
    Fox-Robichaud, A.
    Mbuagbaw, L.
    Szczeklik, W.
    Alshamsi, F.
    Altayyar, S.
    Ip, W.
    Li, G.
    Wang, M.
    Wludarczyk, A.
    Zhou, Q.
    Annane, D.
    Cook, D. J.
    Jaeschke, R.
    Guyatt, G. H.
    INTENSIVE CARE MEDICINE, 2015, 41 (09) : 1561 - 1571
  • [45] Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis
    B. Rochwerg
    W. Alhazzani
    A Gibson
    C. M. Ribic
    A. Sindi
    D. Heels-Ansdell
    L. Thabane
    A. Fox-Robichaud
    L. Mbuagbaw
    W. Szczeklik
    F. Alshamsi
    S. Altayyar
    W. Ip
    G. Li
    M. Wang
    A. Włudarczyk
    Q. Zhou
    D. Annane
    D. J. Cook
    R. Jaeschke
    G. H. Guyatt
    Intensive Care Medicine, 2015, 41 : 1561 - 1571
  • [46] DOES EARLY VASOPRESSOR USE IN SEPSIS RESULT IN BETTER OUTCOMES? A SYSTEMATIC REVIEW AND META-ANALYSIS
    Makhseed, Ethar
    Ghanbar, Mohammad
    Eguale, Tewodros
    CHEST, 2021, 160 (04) : 1109A - 1109A
  • [47] Use of dexmedetomidine in patients with sepsis: a systematic review and meta-analysis of randomized-controlled trials
    Ting Zhang
    Qimin Mei
    Shabai Dai
    Yecheng Liu
    Huadong Zhu
    Annals of Intensive Care, 12
  • [48] SEPSIS: IS IT TIME TO LEAVE SIRS BEHIND? A SYSTEMATIC REVIEW AND META-ANALYSIS OF SEPSIS DEFINITIONS
    Elperin, Jason
    Van Perre, Kimrey
    Nguyen, H. Bryant
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 595 - 595
  • [49] Hydroxyethyl starch 130/0.4 for volume replacement therapy in surgical patients: a systematic review and meta-analysis of randomized controlled trials
    Yi Xu
    Siying Wang
    Leilei He
    Hong Yu
    Hai Yu
    Perioperative Medicine, 10
  • [50] Hydroxyethyl starch 130/0.4 for volume replacement therapy in surgical patients: a systematic review and meta-analysis of randomized controlled trials
    Xu, Yi
    Wang, Siying
    He, Leilei
    Yu, Hong
    Yu, Hai
    PERIOPERATIVE MEDICINE, 2021, 10 (01)